Loading patent…
OwnerAnthony Booth, William T. Sherman +5inventors
InventorsAnthony Booth, William T. Sherman, Peter Raven, James L. Caffrey, Thomas Yorio, Michael Forester, Paticia Gwirtz
Estimating the term…
The present invention provides pharmaceutical compositions which include (−)-pseudoephedrine and a pharmaceutically acceptable carrier, wherein the (−)-pseudoephedrine is substantially-free of (+)-pseudoephedrine. In another embodiment, the present invention provides methods of relieving nasal and bronchial congestion and of inducing pupil dilation which include administering a pharmaceutically effective amount of (−)-pseudoephedrine to a mammal. The (−)-pseudoephedrine used in the present methods is substantially free of (+)-pseudoephedrine and also substantially free of side effects caused by administration of (+)-pseudoephedrine.
A pharmaceutical composition comprising (−)-pseudoephedrine in a therapeutically acceptable dosage and a pharmaceutically acceptable carrier, wherein said (−)-pseudoephedrine is substantially-free of (+)-pseudoephedrine.
A method of relieving nasal and bronchial congestion which comprises administering a pharmaceutically effective amount of (−)-pseudoephedrine to a mammal, wherein said (−)-pseudoephedrine is substantially free of (+)-pseudoephedrine.
A method of dialating the pupil which comprises administering a pharmaceutically effective amount of (−)-pseudoephedrine topically to a mammal, wherein said (−)-pseudoephedrine is substantially-free of (+)-pseudoephedrine.
Dependencies are inferred from the claim text.